TrialCancer2025

Efficacy, safety, and pharmacokinetics of teclistamab in Chinese patients with relapsed/refractory multiple myeloma from the China cohort of MajesTEC-1.

Zhen Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.